Analysis of surgical treatments for bone metastases in the proximal femur

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study collects data from patients who underwent surgical treatment for impending or pathological fractures of the proximal femur due to bone metastases between 2000 and 2023. It focuses on analyzing outcomes from various surgical interventions, including intramedullary nails and prosthetic reconstructions. The investigators will review medical records, radiological imaging, and histological data to assess the effectiveness of these treatments. Approximately 600 patients are expected to be included in the analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male and female adult patients surgically treated between 01/01/2000 and 31/12/2023 in Rizzoli Orthopaedic Institute and in Massachusetts General Hospital.
* Age ≥18 y (at the time of surgery)
* Patients with impending or pathological fracture due to bone metastases of the proximal femur (head/neck, intertrochanteric, subtrochanteric area).
* Patients who underwent either IMN or THA or HHA or Mega or MegaTHA.
* Patients with available clinical and imaging data.

Exclusion Criteria:

* Patients with pathological or impending fracture of proximal femur due to primary bone tumor.

Where it's running

• Irccs Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy Recruiting

Study contacts

• Study coordinator: Costantino Errani, MD
• Email: costantino.errani@ior.it
• Phone: 0516366

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prophylactic Radiotherapy to Prevent Bone Complications in Metastatic Cancers

  This study tests whether giving early radiotherapy to high-risk bone metastases, in addition to standard care, can reduce bone-related problems in adults with metastatic solid cancers.

  Recruiting Phase 2 Institute of Oncology Ljubljana · Ljubljana · NCT07540650

• Focused high-dose SBRT for spinal tumors

  This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.

  Recruiting at 2 sites Institute of Oncology Ljubljana · Ljubljana and 1 other locations · NCT07429422

• Registry for people with symptomatic bone metastases

  This registry collects health information from adults with symptomatic bone metastases who need treatment for painful or unstable bone lesions to learn more about outcomes and care.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07391410

• One-visit, simulation-free single-dose radiation for painful bone metastases

  This trial tests whether adults with one or two painful bone metastases can get pain-relieving radiation in a single visit using a simulation-free planning approach.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07202273

• Dual Energy CT to Delineate Tumors and Organs at Risk in Radiotherapy

  This study tests whether dual-energy CT can delineate tumors and nearby critical tissues as well as MRI for patients needing radiotherapy.

  Recruiting at 2 sites Aalborg University Hospital · Aalborg and 2 other locations · NCT07185958

• Early radiotherapy versus observation for high‑risk painless or minimally painful bone metastases

  This will test whether giving preventive radiotherapy to people with high‑risk but painless or minimally painful bone metastases can reduce future bone complications, hospital stays, and symptoms compared with observation and usual treatment.

  Recruiting at 6 sites Cancer Research Antwerp · Wilrijk, Antwerp and 7 other locations · NCT07146074

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.